Pages that link to "Q28249217"
Jump to navigation
Jump to search
The following pages link to Stool Form Scale as a Useful Guide to Intestinal Transit Time (Q28249217):
Displaying 50 items.
- An in-depth analysis of a piece of shit: distribution of Schistosoma mansoni and hookworm eggs in human stool (Q21092276) (← links)
- A randomized controlled trial of glucose versus amylase resistant starch hypo-osmolar oral rehydration solution for adult acute dehydrating diarrhea (Q21144349) (← links)
- Interventions for preventing postpartum constipation (Q24187123) (← links)
- Interventions for preventing postpartum constipation (Q24187521) (← links)
- Laxatives for the management of constipation in people receiving palliative care (Q24187956) (← links)
- Interventions for treating postpartum constipation (Q24193478) (← links)
- Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation (Q24607588) (← links)
- Chronic constipation: current treatment options (Q24632528) (← links)
- Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis (Q24635181) (← links)
- Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function (Q24647522) (← links)
- Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition (Q26745952) (← links)
- Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis (Q26748476) (← links)
- Inflammation in irritable bowel syndrome: Myth or new treatment target? (Q26768545) (← links)
- Irritable bowel syndrome and chronic constipation: Fact and fiction (Q26777547) (← links)
- Evolving paradigms in the treatment of opioid-induced bowel dysfunction (Q26777692) (← links)
- Management of regorafenib-related toxicities: a review (Q26795561) (← links)
- Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation (Q26830397) (← links)
- Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction (Q27010907) (← links)
- Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study (Q28242569) (← links)
- Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children (Q28247362) (← links)
- Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infection (Q28658118) (← links)
- Diet rapidly and reproducibly alters the human gut microbiome (Q29547454) (← links)
- An experimental investigation of the combustion performance of human faeces. (Q30061898) (← links)
- Hepatocyte growth factor, hepatocyte growth factor activator and arginine in a rat fulminant colitis model (Q30276866) (← links)
- Probiotics for Clostridium difficile infection in adults (PICO): Study protocol for a double-blind, randomized controlled trial (Q30354419) (← links)
- Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndrome (Q30960103) (← links)
- British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults (Q31054269) (← links)
- Association of food-hygiene practices and diarrhea prevalence among Indonesian young children from low socioeconomic urban areas (Q31141997) (← links)
- Bloating in constipation: Relevance of intraluminal gas handling (Q33449647) (← links)
- Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders (Q33449885) (← links)
- A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life (Q33455506) (← links)
- Polydextrose and soluble corn fiber increase five-day fecal wet weight in healthy men and women (Q33457219) (← links)
- A pilot study on the effect of a symbiotic mixture in irritable bowel syndrome: an open-label, partially controlled, 6-month extension of a previously published trial (Q33458837) (← links)
- New onset of constipation during long-term physical inactivity: a proof-of-concept study on the immobility-induced bowel changes. (Q33459003) (← links)
- Symptom patterns can distinguish diverticular disease from irritable bowel syndrome (Q33459058) (← links)
- Digestive tolerance and postprandial glycaemic and insulinaemic responses after consumption of dairy desserts containing maltitol and fructo-oligosaccharides in adults (Q33461093) (← links)
- Gastrointestinal tolerance and utilization of agave inulin by healthy adults (Q33461125) (← links)
- Symptom outcomes important to women with anal incontinence: a conceptual framework. (Q33461472) (← links)
- High-Fiber Orange Juice as a Nutrition Supplement in Women: A Randomized, Double-Blind, Placebo-Controlled Study of Tolerance and Effectiveness (Q33461950) (← links)
- A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat (Q33465330) (← links)
- Prebiotic Potential of a Maize-Based Soluble Fibre and Impact of Dose on the Human Gut Microbiota (Q33466878) (← links)
- Acupuncture for cancer pain and related symptoms (Q33558685) (← links)
- The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis (Q33586866) (← links)
- Processing faecal samples: a step forward for standards in microbial community analysis (Q33611925) (← links)
- Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship. (Q33624179) (← links)
- Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial (Q33639963) (← links)
- Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags (Q33645951) (← links)
- Pain symptoms and stooling patterns do not drive diagnostic costs for children with functional abdominal pain and irritable bowel syndrome in primary or tertiary care (Q33651581) (← links)
- Perilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study (Q33687137) (← links)
- Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study (Q33693688) (← links)